MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
AFL HOLD REF $118 PW TARGET $122 (+3% vs spot · 12m PWEV) +3% Single-name research · 25 August 2026
Equity ResearchFinancials · Life & Health Insurance
AFL

Aflac Incorporated (AFL)

HOLD. 12-month probability-weighted target $122 (+3% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

HOLD RESEARCH mature cash generator 25 August 2026
$118 $122 (+3% vs spot · 12m PWEV) +3% 12-month probability-weighted
Expected return (1y)+3.0%
Margin of safety-0.6%
Quality67/100
Upside / downside1.5×
Downside probability+56%
Expected alpha (1y)-2.1%
Forward P/E14.3x
Independent DCF
Valuation confidencemedium
Key metric to watchTotal net earned premium growth, year on year
The case. narrow moat, mature cash generator
The problem. house above consensus; Total net earned premium growth, year on year
What changes our mind. Total net earned premium growth, year on year < 0.025

Model history: the direction implied by our targets has been right 43.6% of the time across 480 pre-registered anchors — below a coin flip. Treat the expected return as a distribution estimate, not a point forecast. This name's record ↓ · full record.

Not personalised investment advice · full disclosures in Part 9 below.

Contents
01Investment Decision

Investment Committee Summary

Rating HOLD
Internal 5-tier HOLD
Classification · conviction mature cash generator · medium
Evidence 8/8 load-bearing inputs sourced
Triangulated fair value $117 (-1% vs spot · triangulated FV)
12-mo scenario PWEV $122 (+3% vs spot · 12m PWEV)
Next catalyst 2026-09-18 — Japan (JPY/USD) hedging and investment-portfolio strategy update
Primary thesis-break Total net earned premium growth, year on year < 0.025 (2 consecutive prints)
Decision detail — rating tables & Research OS strip

Rating: HOLD

Internal 5-tier: HOLD · mature cash generator · analyst conviction: medium

Metric Value
Current Price $118
Triangulated Fair Value $117 (-1% vs spot · triangulated FV)
12-mo Scenario PWEV $122 (+3% vs spot · 12m PWEV)
Forward P/E 14.3x
Market Cap $61B
52-Week Range $94.92–$129 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale)

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Decision Support — Research OS jump to detail ↓

Research conviction Exp. return (1y) Rules stance Preferred options Next catalyst
58.9/100 (53rd pct) +3% 1yr expected Hold Covered Call 24d — Japan (JPY/USD) hedging and investment-portfolio strategy update

Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Recommendation: HOLD

Balanced: triangulated fair value $117 (-1% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

02Thesis, Anti-Thesis & Variant View

Investment Thesis

At $118 (25 August 2026) Aflac trades on 14 times forward earnings, the richest quality premium in its insurer peer group. The market is paying for stability: a return on equity comfortably above the cost of equity, a dividend alongside substantial repurchases, and a supplemental-health franchise with little underwriting volatility. The engine is less generous. The peer earnings-multiple work implies a materially lower value, and a substantial combined weight on the soft-market and reserve-reset states holds the probability-weighted value to $122 and the base-path target to $124, both close to the current price. Triangulated fair value of $117 leaves the shares fairly valued against the anchor set, -1% against spot. The rating is HOLD: the premium is already in the price and the blend does not clear the threshold that would justify paying more. The most damaging risk is a credit-and-reserve reset that values the shares far below the 52-week low.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($118) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The four weighted valuation anchors bracket the <img src=
Integrated dashboard. The four weighted valuation anchors bracket the $118 spot from $82.00 to $127 — fairly valued — spot brackets the blend.

Anti-Thesis (The Real Bear Case)

Aflac's earnings stability rests on a Japanese block in slow run-off and an investment portfolio that has already produced commercial-real-estate impairments. The structural scenario is a plausible chain, not a tail: yen weakness compresses translated earnings while lapses rise on an ageing policy base; credit losses in transitional real estate and below-investment-grade holdings force realised impairments; and US group products face benefit-ratio normalisation after unusually favourable claims years. In that path revenue contracts, the operating margin falls well below 28%, earnings per share compress sharply, and the multiple de-rates from 14 times into the low double digits as the quality-compounder narrative breaks. The result values the shares below the 52-week low, and the entry multiple offers no cushion against it.

Key Debate

P/E Multiple explains 70% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 16.8× consensus forward EPS, and a peer median 9.9×.

Variant perception: the house view is above-consensus, and the thesis is primarily growth-driven.

Metric Consensus House Importance
Revenue 17.0 19.0 High
EPS 7.0 8.3 Medium
Target price 119.2 124.0 Medium
03Scenario & Valuation

Scenario Analysis

The scenario tree spans a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($54.30) to a 'Bull — Re-Rate' bull case ($215); the probability-weighted blend (PWEV $122) is +3% versus spot.

Scenario Probability Target Return vs spot
Structural — Underwriting / Reserve / Catastrophe Reset 20% $54.30 -54%
Soft Market / Investment Loss 17% $91.60 -23%
Base — Mid-Cycle Combined Ratio 35% $125 +5%
Growth — Hard Market / Pricing + Float Income 20% $172 +46%
Bull — Re-Rate 8% $215 +82%
Probability-Weighted (PWEV) $122 +3%

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $2.56B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

  • Structural — Underwriting / Reserve / Catastrophe Reset (20%, $54.30). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
  • Soft Market / Investment Loss (17%, $91.60). Cyclical downturn — premium growth + underwriting margin + investment income + reserves weakens for 1–2 years before normalising.
  • Base — Mid-Cycle Combined Ratio (35%, $125). Mid-cycle — normalised premium growth + underwriting margin + investment income + reserves; disciplined capital allocation; steady returns.
  • Growth — Hard Market / Pricing + Float Income (20%, $172). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly.
  • Bull — Re-Rate (8%, $215). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing.
Five-scenario tree. Probability-weighted targets around the <img src=
Five-scenario tree. Probability-weighted targets around the $118 spot; PWEV $122 (+3% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $54.30–$215)

Valuation Triangulation

Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat four numbers as four independent votes.

Method Basis Fair Value vs Spot Weight in this name's blend
Monte Carlo median (Student-t + regime) multiple $111 -6% 18% (declared 15%)
Peer P/E re-rate multiple $82.00 -31% 12% (declared 10%)
Peer EV/Revenue re-rate multiple $39.55 -67% 0% — cross-check only
Scenario PWEV multiple $122 +3% 29% (declared 25%)
Justified P/B (ROE-based) book value × ROE $127 +8% 41% (declared 35%)
Triangulated (weighted) $117 -1% 100%

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Book Value, ROE & Capital Returns

For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).

Metric Value
Book value / share $58.69
Return on equity (ROE) 16.5%
Cost of equity (assumed) 9.5%
Current P/B 2.01x
Justified P/B (ROE-based) 2.17x
Justified value / share $127 (+8%)

ROE of 16.5% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 2.17x (vs 2.01x current) is warranted. The justified value sits +8% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $111 and 44% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (70% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median <img src=
Monte Carlo distribution. Median $111; P(price > current) 44%. P10–P90: $65.27–$176.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 9.9x) implies $82.00. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 9.9x → $82.00; EV/Rev re-rate → $39.55.
Cross-sectional peer benchmarking. Peer-median fwd P/E 9.9x → $82.00; EV/Rev re-rate → $39.55.

Across all anchors the spread is 79% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
MET 9.3× 5% 10% segment 50%
PRU 10.5× 5% 5% segment 50%
PFG 9.4× 5% 15% segment 50%
GL 10.4× 5% 24% segment 50%

Quality-weighted forward P/E: 9.9× (simple median 9.9×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $94.92–$129, centre $111 (-6% vs spot); spot sits at the 69th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $117 (-1% vs spot · triangulated FV)
Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) $54.30 (-54% vs spot · bear scenario)
Reward-to-risk ratio withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg
Margin of safety (FV vs spot) -1%
P(price > spot) — Monte Carlo 44%

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $215.

04Business & Financial Quality

Company Overview & Business Model

Aflac Incorporated — FINANCIAL SERVICES · INSURANCE - LIFE. Aflac Inc. (American Family Life Assurance Company) is an American insurance company and is the largest provider of supplemental insurance in the United States.

How it makes money.

Segment Rev mix Growth Op margin Key driver
Insurance (Underwriting + Float) 100% +5% 28% premium growth + underwriting margin + investment income + reserves

Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Insurance (Underwriting + Float) $18.1B 100% 5% 28% $5.1B 15.0x 1% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver premium growth + underwriting margin + investment income + reserves
net_debt_or_cash_b -2.25

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.01
div_yield 0.0199

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside underwriting / reserve / catastrophe reset
upside hard market + pricing

Balance Sheet & Liquidity

Metric Value
Net debt $-62.0B — net cash
Net debt / EBITDA -10.22x
Interest coverage (EBIT / interest) 21.1x
Current ratio 12.39x
Lease obligations $0.1B
Cash & ST investments $70.4B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $2.6B
Buybacks / dividends $3.5B / $1.2B
Total shareholder yield 7.8%
Payout as % of FCF 185.0%
Allocation stance returning more than FCF (balance-sheet funded)

Free-Cash-Flow Quality

Metric Value
FCF margin 14.1%
FCF conversion (FCF / net income) 70.1%
FCF yield 4.2%
Capex intensity (capex / revenue) 0.0%
FCF − SBC (diagnostic) $2.6B
Capex split (maint / growth) 80% / 20% — Capital-light insurer - physical capex is negligible (~1% of revenue) and the AV capex line is a known data gap; spend is systems/technology maintenance with a minority for distribution and digital-enrollment build. The real 'capital' story is investment-portfolio and buyback allocation, not PP&E.

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 70% — earnings not cash-backed.

Competitive Moat

Moat sources:

  • Dominant supplemental-health share in Japan (worksite/agency distribution moat)
  • US supplemental franchise with worksite-enrollment relationships
  • Low-volatility underwriting book (supplemental, not P&C catastrophe exposure)
  • 16.5% ROE vs ~9.5% cost of equity - a genuine but spread-based, not pricing-power, advantage
05Earnings, Consensus & Catalysts

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.23 vs analyst floor +0.00delta +0.23 (n=26 mgmt / 16 Q&A; 15th pctile across the S&P book, z -1.1).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

Quarter Mgmt Analyst Delta
2026Q2 +0.23 +0.00 +0.23
2026Q1 +0.33 +0.00 +0.33
2025Q4 +0.44 +0.00 +0.44
2025Q3 +0.40 +0.00 +0.40

News (last 365d, 1269 articles): avg ticker sentiment +0.08 (bullish 16% / bearish 4%)

Consensus & Market Expectations

Reference Value
Street target (mean) $119 (+1% vs spot · street)
House target $124 (+4.1% vs street)
Sell-side coverage 14 analysts (SB 2 / B 1 / H 8 / S 2 / SS 1; net score 0.04)
Consensus FY EPS $7.04; house above (+17.5%)
Consensus FY revenue $17.0B; house above (+11.9%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

  • 2026-09-18 (~25d) — Japan (JPY/USD) hedging and investment-portfolio strategy update (authored)
  • 2026-11-04 (~72d) — FY2026 results with Japan persistency and US sales-growth update (authored)
  • 2027-02-10 (~170d) — Capital-management / buyback and dividend update (FY2027 plan) (authored)

Forecast Track Record

  • EPS surprise: beat 38% of the last 8 quarters; average surprise +7.1%.
  • Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 67%; mean predicted -0.1% vs realised -4.8%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.

When Catalyst Type Importance Confidence
2026-09-16 (in 22d) FOMC rate decision + SEP dot plot macro ●● 0.8
2026-09-18 (in 24d) Japan (JPY/USD) hedging and investment-portfolio strategy update authored 0.7
2026-09-18 (in 24d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2026-10-14 (in 50d) September CPI macro ●● 0.8
2026-10-28 (in 64d) FOMC rate decision + press conference macro ●● 0.8
2026-11-04 (in 71d) FY2026 results with Japan persistency and US sales-growth update authored 0.7
2026-12-09 (in 106d) FOMC rate decision + SEP dot plot macro ●● 0.8
2026-12-18 (in 115d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2027-01-27 (in 155d) FOMC rate decision + press conference macro ●● 0.8
2027-02-10 (in 169d) Capital-management / buyback and dividend update (FY2027 plan) authored 0.7
2027-03-17 (in 204d) FOMC rate decision + SEP dot plot macro ●● 0.8
2027-03-19 (in 206d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2027-04-28 (in 246d) FOMC rate decision + press conference macro ●● 0.8
2027-06-09 (in 288d) FOMC rate decision + SEP dot plot macro ●● 0.8

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

06Risks & Falsification
Issue Probability Valuation sensitivity Horizon
Japan FSA solvency / capital regime (economic value-based ESR) and JPY-hedging cost regulation medium (~40%) medium - Japan is the majority of earnings; capital-regime shifts ~5-8% of FV 12-24m
US supplemental-health / worksite-benefits regulatory and tax treatment changes low (~20%) low - stable regulatory backdrop for supplemental products; <3% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Underwriting / Reserve / Catastrophe Reset A structural deterioration in the supplemental-health book (adverse claims, reserve strengthening) plus a Japan persistency decline resets earnings power lower; the quality premium unwinds. Reserve inadequacy surfaces alongside falling Japan persistency, hitting both book value and the multiple.
Soft Market / Investment Loss A soft-pricing insurance market plus investment losses on the float portfolio (credit marks, JPY-hedge costs) compress the ROE below the through-cycle trend. Falling rates cut float income while FX/hedge costs rise, squeezing the spread from both ends.
Base — Mid-Cycle Combined Ratio A normalized combined ratio with stable Japan persistency and steady float income sustains a mid-teens ROE; per-share value compounds via buybacks. The ~14x premium to a ~10x peer median compresses even if underwriting is fine - the market simply re-rates the group.
Growth — Hard Market / Pricing + Float Income A hard supplemental-pricing market plus rising rates lift both underwriting margin and float income, expanding the ROE above trend. Hard-market pricing gains are competed away, and rising rates that help float also mark down the existing bond portfolio.
Bull — Re-Rate A flight-to-quality bid plus accelerated buybacks re-rate Aflac toward a scarcity multiple for low-volatility insurance earnings. Re-rating an already-premium insurer leaves no cushion if Japan persistency or reserve adequacy disappoints.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Rule Condition Observed Triggered
R1-valuation-stretch expected return vs fair value < -12 (upside_pct) 4.95 no
R2-valuation-opportunity expected return vs fair value > 15 (upside_pct) 4.95 no
R3-street-revisions street net rating stance < -0.25 (extended.consensus.street_score) 0.04 no
R4-earnings-quality cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) 70.1 YES
R5-technical-breakdown price vs 200-day SMA < 0.85 (technicals.sma_200) 1.04 no
R6-vol-regime-shift IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) 0.98 no

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Total net earned premium growth, year on year < 0.025 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Pre-tax adjusted operating margin < 0.26 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Aflac Japan persistency rate, % < 93 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Net investment losses including credit impairments, quarterly $M > 300 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
  • Adjusted return on equity < 0.13 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

  • FACT: Spot $118; 52-week range $94.92–$129; engine rating HOLD; house target $124 (+5%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
  • INFERENCE: Triangulated FV $117 (-1% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
07Portfolio & Options

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

58.9/100 (confidence band 46.4–71.4), 53rd percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Component Score (0–100) Weight Inputs
business quality 67 15% extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct
financial strength 92 10% extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage
valuation 55 15% upside_pct
growth 52 10% reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions
earnings visibility 38 10% extended.forecast_accuracy.eps_surprise.beat_rate_pct
moat 56 10% enrichment.moat.rating
technical trend (heuristic — no validation record; weight change reserved for AM-060) 47 10% technicals.rsi, technicals.sma_50, technicals.sma_200
macro tailwinds 10% industry_context.house
risk profile 61 10% monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 61.1 → 61.1 → 58.5 → 60.4 → 60.4 → 58.8 → 58.8 → 58.8.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

Scenario Probability Target Total return Contribution
Structural — Underwriting / Reserve / Catastrophe Reset 20% $54.30 -54.1% -10.8pp
Soft Market / Investment Loss 17% $91.60 -22.5% -3.8pp
Base — Mid-Cycle Combined Ratio 35% $125 +5.5% +1.9pp
Growth — Hard Market / Pricing + Float Income 20% $172 +45.5% +9.1pp
Bull — Re-Rate 8% $215 +82.2% +6.6pp
Aggregate Value
Expected return (gross, 1y) +3.0%
Expected return net of SBC dilution +3.0%
Outcome dispersion (σ, from MC p10–p90) 36.5%
Expected Sharpe (rf 4%) -0.03
Downside expectation (prob-weighted loss branches) -14.6%

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

Component Value
Expected return (gross, 1y) 3.0%
Risk-free rate 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13)
Beta (shrunk, 1y vs SPY) 0.25 (as of 2026-08-24)
Equity risk premium 4.5%
Required return 5.1%
Expected alpha -2.1%
Alpha per unit risk (EA/σ) -0.06

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Cross-check Ours Comparator Reading
Scenario spread vs options market 40.3% (1σ) 14.5% implied our scenarios are far wider than the options market prices
Mass above spot: scenarios vs our own MC 63.0% 43.7% the two expressions of our own view agree
Realised scenario frequency 23 dated anchors 23 dated anchors available; realised-vs-prior comparison is now meaningful.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $121.71.

Flagged for review: scenario spread vs the options market. A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Style Percentile Theme Percentile
Growth 48 AI 8
Value 83 Cloud 13
Quality 25 Semis 12
Momentum 66 Consumer 8
Low-Vol 84 Rates 11
USD 93
Energy 79

Market interaction: correlation vs SPY +0.26, vs QQQ +0.10 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

  • range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
  • Direction neutral from the overlay conviction/rating (read-only input).
  • IV/RV at the 71st percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
  • Reported alongside and not used to select: this name's own ATM IV sits at the 67th percentile of its own month-end history (decile 7).
  • IV term structure is in contango (longer-dated richer, slope +5.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +5.9pp): 32-DTE 19% · 88-DTE 21% · 389-DTE 25%

Priced structure Value
Legs Short 126 C
Expiry 2026-09-25
Income yield 0.0%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Parameter Value
Initial position 0.50% NAV
Maximum position 0.83% NAV
Risk budget 1.38% NAV
Annualized outcome σ (MC) 36.5%
Indicative holding period 3–12 months
Liquidity high, ~$248M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit
Rebalancing trigger position drifts ±25% from target weight, or the decision-rules stance changes

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 19.0% (moderate regime) · expected move ±4.3% (2026-09-25) · put/call OI 0.62 · ATM Δ 0.55 / Θ -0.04 / ν 0.14. Direction: NEUTRAL (implied return -6.4% to triangulated fair value $110.64).

Covered Call (if held) (Income / neutral) — Short 126 C · 2026-09-25 · premium $0.01 · yield 0.0% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 109 P / Long 100 P · 2026-10-02 · net $0.49 · net entry $108.51 · yield 0.4% · RoR 6.0% · max loss $8.51 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 105 P / Short 130 C · 2027-02-19 · net $0.77 · floor -11.0% · cap +10.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

08Model Transparency

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies +3% vs spot
  • Monte Carlo median implies -6% vs spot
  • DCF fair value implies +8% vs spot
  • Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -54% vs spot
  • Net: the valuation anchor itself sits 0.6% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Assumption Register

Assumption Value Used in Source
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $18.1B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $19.0B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $7.0396 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.512B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $-61.989B reported fact Balance sheet via AV High EV, DCF equity bridge

Research Provenance

Field Value
Quantitative engine mch_stock_engine v2.0
Research OS config ros-1.19.0
Analysis as-of 2026-08-25 (prices 2026-08-24)
Narrative authorship claude-opus-5 · Claude Code, supervised, drafted 2026-08-16
Human review Marinus 2026-08-16
Evidence 8/8 load-bearing inputs sourced; 13/14 mandated claims cited
QA scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here

Load-Bearing Assumptions

DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.

09Appendix & Audit Trail
Appendix & audit trail — source log, data provenance, disclosures

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-08-24 Price, market cap, EV, forward P/E Alpha Vantage 2026-08-24
MCH engine — trailing 252 adjusted closes derived 2026-08-24 52-week range (vendor's recorded range was stale and was replaced) trailing 252 sessions of own close history; config value was stale
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-08-24 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-08-24 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-08-24 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-08-24 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-08-24 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-08-24 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-08-24 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Data Sources

  • Prices, fundamentals, options chain, earnings — Alpha Vantage.
  • Company filings (10-K / 10-Q)SEC filings via EDGAR.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.

Forecast record. Across 480 pre-registered anchors, the direction implied by our targets has been right 43.6% of the time — below the 50% a coin flip would give, with a Brier score of 0.268 against 0.25 for that same coin flip (lower is better). The tier-level picture is mixed: sector-relative alpha on SELL calls excludes zero, on BUY calls it does not, and the flattering aggregate is carried by HOLD, which counts as a hit merely for tracking its benchmark. Read the target below with that in mind — and see the full accuracy record. Samples are thin and windows short; nothing here is settled in either direction.

Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.